GlassScriptPhysician profile
Sandra J Sultan
NPI 1811041718
$3,733.91
in general payments reported to CMS, 2019-2025
28 companies · $1,731 in 2025
The $1,731 reported for 2025 was more than what 94% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.91 · 2021: $15.52 · 2022: $19.06 · 2023: $376 · 2024: $1,557 · 2025: $1,731.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,402 · Education: $262.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,402.49 |
| Education | $261.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $910.43 | 2024-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $423.31 | 2024-2025 | Caplyta |
| Abbvie INC. | $331.36 | 2023-2025 | Liletta |
| Astellas Pharma US INC | $324.07 | 2023 | Mycamine, Veozah |
| Novo Nordisk INC | $273.17 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Dexcom, INC. | $227.63 | 2024-2025 | Dexcom G6 Transmitter |
| Kowa Pharmaceuticals America, INC. | $144.53 | 2024-2025 | Zoryve |
| Bausch Health US, LLC | $143.02 | 2024-2025 | Aplenzin |
| Janssen Pharmaceuticals, INC | $133.81 | 2024-2025 | Spravato |
| Bayer Healthcare Pharmaceuticals INC. | $95.05 | 2024-2025 | |
| Abbott Laboratories | $88.61 | 2025 | Freestyle Libre 3 |
| Astrazeneca Pharmaceuticals LP | $84.89 | 2024-2025 | Breztri, Airsupra |
| Lilly USA, LLC | $81.96 | 2024-2025 | Zepbound, Jardiance, Mounjaro |
| Pfizer INC. | $70.67 | 2019-2025 | |
| Xeris Pharmaceuticals, INC. | $70.12 | 2024-2025 | Gvoke Hypopen |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $42.75 | 2024-2025 | Voquezna |
| Philips North America LLC | $37.75 | 2024 | (Ck4) Mcot |
| Edwards Lifesciences Corporation | $26.83 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Axsome Therapeutics, INC. | $26.33 | 2025 | Auvelity |
| Medtronic, INC. | $26.30 | 2025 | Venaseal |
| Seqirus USA INC | $24.85 | 2024 | Flucelvax, Fluad |
| Therapeuticsmd, INC. | $23.93 | 2019 | |
| Sumitomo Pharma America, INC. | $23.01 | 2023 | Gemtesa |
| Phadia US INC. | $22.99 | 2024 | Immunocap |
| Exact Sciences Corporation | $22.89 | 2025 | Cologuard Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $20.83 | 2024 | Trintellix |
| Teva Pharmaceuticals USA, INC. | $17.30 | 2025 | Austedo Xr |
| Agile Therapeutics, INC. | $15.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Sultan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.